1. Efficacy of tibolone as “add-back therapy” in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids 
Edward Patrick Morris, M.D., Janice Rymer, M.D., Jill Robinson, R.G.N., Ignac Fogelman, M.D. 
Fertility and Sterility 
Volume 89, Issue 2, Pages (February 2008)
DOI: /j.fertnstert
Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions

2. Figure 1
Bone mineral density, mean percentage change (±SEM). ∗P<.05 vs. groups A and C; ∗∗P<.05 vs. group C; ∗∗∗P<.0001 vs. group C.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions

3. Figure 2
Mean vasomotor scores (±SEM). ∗P<.05 vs. group B; ∗∗P<.001 vs. group B; ∗∗∗P<.0001 vs. group B; ∗∗∗∗P<.001 vs. group C.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions

4. Figure 3
Mean total days of vaginal bleeding. ∗P<.05 vs. group B; ∗∗P<.001 vs. group B; ∗∗∗ P<.0001 vs. group B.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions